[Essential arterial hypertension, cellular intolerance to sodium]

Area of Science:

• Biochemistry
• Physiology
• Cardiovascular Research

Context:

• Elevated intracellular sodium (Na+) concentration is implicated in hypertension pathogenesis, particularly in excitable cells.
• The Na+ pump, mediated by Na+-K+-ATPase, actively extrudes Na+ in exchange for potassium (K+), regulating intracellular sodium levels.
• Cardiotonic glycosides like digitalis and ouabain are known inhibitors of the Na+ pump.

Purpose:

• To investigate the existence and characteristics of an endogenous system that modulates Na+ pump activity.
• To determine the potential role of this endogenous system in the development of essential hypertension.

Summary:

• Experimental and clinical data suggest an endogenous inhibitor of the Na+ pump, functionally similar to ouabain, exists.
• Administration of Na+ enhances this inhibitor's effect in urine and plasma.
• Approximately 50% of essential hypertension patients exhibit elevated levels of this inhibitor, potentially linked to familial or genetic factors.
• The inhibitor is biochemically characterized as a small (molecular weight < 3000), thermostable, anionic molecule.

Impact:

• This endogenous inhibitor may play a dual role in regulating Na+ turnover and contributing to hypertension pathology.
• Understanding this inhibitor could reveal new therapeutic targets for managing hypertension.
• Its competitive inhibition with other cations like K+ offers insights into Na+ pump regulation mechanisms.